A detailed history of Nvidia Corp transactions in Recursion Pharmaceuticals, Inc. stock. As of the latest transaction made, Nvidia Corp holds 7,706,363 shares of RXRX stock, worth $53.4 Million. This represents 14.7% of its overall portfolio holdings.

Number of Shares
7,706,363
Previous 7,706,363 -0.0%
Holding current value
$53.4 Million
Previous $76.8 Billion 24.77%
% of portfolio
14.7%
Previous 23.09%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 14, 2024

BUY
$5.09 - $10.79 $39.2 Million - $83.2 Million
7,706,363 New
7,706,363 $76 Billion

Others Institutions Holding RXRX

About RECURSION PHARMACEUTICALS, INC.


  • Ticker RXRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 180,480,000
  • Market Cap $1.25B
  • Description
  • Recursion Pharmaceuticals, Inc. operates as a clinical-stage biotechnology company, engages in the decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering to industrialize drug discovery. The company develops REC-994, which is in Phase IIa clinical trial to treat cerebral cav...
More about RXRX
Track This Portfolio

Track Nvidia Corp Portfolio

Follow Nvidia Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nvidia Corp, based on Form 13F filings with the SEC.

News

Stay updated on Nvidia Corp with notifications on news.